| Tori Jolly, PA | |
|
131 Rinehart Way, Aiken, SC 29803-1703 | |
| (803) 335-2200 | |
| (803) 649-7966 |
| Full Name | Tori Jolly |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 131 Rinehart Way, Aiken, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003409780 | NPI | - | NPPES |
| 4472 | Other | SC | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 0010-11042 (North Carolina) | Secondary |
| 363A00000X | Physician Assistant | 4472 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aiken Regional Medical Center | Aiken, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Primary Care Pc | 4385633247 | 47 |
| Center For Primary Care Pc | 4385633247 | 47 |
News Archive
A team of scientists from Princess Margaret Hospital have created an organic nanoparticle that is completely non-toxic, biodegradable and nimble in the way it uses light and heat to treat cancer and deliver drugs.
A new study suggests that many women do feel depressed after sex. The study involved more than 200 young Australian women who were questioned about their sex lives. At least one in three young women said they experienced post-coital blues at some point in their lives. Ten per cent said they frequently or almost always felt sad after making love. The study was published in the quarterly International Journal of Sexual Health.
In the scientific journal PLoS ONE, Sara Bartels and Siegfried Weiss of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany now show how the bacteria migrate into tumours. A messenger substance from the immune system is the door opener: It makes blood vessels in the cancerous tissue permeable; enabling the bacteria to conquer and destroy the tumour.
Dr. Barry Reiner announced that he is now recruiting children and adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.
Writing in the International Health Policies blog, Rachel Hammonds of the Institute of Tropical Medicine in Belgium, writes about a "panel discussion organized by several [members of the European Parliament], the Stop Aids Alliance and others at the European Parliament on 8 April" that discussed the Global Fund to Fight AIDS, Tuberculosis and Malaria.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tori Jolly, PA Po Box 2510, Evans, GA 30809-2510 Ph: (706) 922-8274 | Tori Jolly, PA 131 Rinehart Way, Aiken, SC 29803-1703 Ph: (803) 335-2200 |
News Archive
A team of scientists from Princess Margaret Hospital have created an organic nanoparticle that is completely non-toxic, biodegradable and nimble in the way it uses light and heat to treat cancer and deliver drugs.
A new study suggests that many women do feel depressed after sex. The study involved more than 200 young Australian women who were questioned about their sex lives. At least one in three young women said they experienced post-coital blues at some point in their lives. Ten per cent said they frequently or almost always felt sad after making love. The study was published in the quarterly International Journal of Sexual Health.
In the scientific journal PLoS ONE, Sara Bartels and Siegfried Weiss of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany now show how the bacteria migrate into tumours. A messenger substance from the immune system is the door opener: It makes blood vessels in the cancerous tissue permeable; enabling the bacteria to conquer and destroy the tumour.
Dr. Barry Reiner announced that he is now recruiting children and adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.
Writing in the International Health Policies blog, Rachel Hammonds of the Institute of Tropical Medicine in Belgium, writes about a "panel discussion organized by several [members of the European Parliament], the Stop Aids Alliance and others at the European Parliament on 8 April" that discussed the Global Fund to Fight AIDS, Tuberculosis and Malaria.
› Verified 6 days ago
Erin P Stewart, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 131 Rinehart Way, Aiken, SC 29803 Phone: 803-335-2200 Fax: 803-649-7966 | |
Mr. William Kevin Higgins, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 302 University Pkwy, Aiken, SC 29801 Phone: 806-641-5100 | |
Mr. Michael Edward Spillane, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 440 Society Hill Dr Ste 100a, Aiken, SC 29803 Phone: 032-260-1028 Fax: 803-226-0384 | |
Ms. Veronica Marie Chavis, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 137 Miracle Drive, Nw, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Jory Gibbons Croft, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: Aiken Specialty Services, 209 Abbeville Ave Nw, Aiken, SC 29801 Phone: 803-306-1433 | |
Stephen Rozier, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1520 Two Notch Rd Se, Aiken, SC 29803 Phone: 803-649-3909 Fax: 803-642-8495 |